vi
ANALISIS EFEKTIVITAS BIAYA PENGOBATAN
HIPERTENSI DAN DIABETES MELITUS
DI RUMAH SAKIT UMUM PUSAT HAJI ADAM MALIK
PADA PERIODE JANUARI 2014 -JUNI 2014
.
ABSTRAK
Hipertensiadalahkeadaandimanamenigkatnyatekanandarah diatas normal(≥140/90 mmHg).Prevalensinya di Indonesia 32,2% danhanya 24,2%
daripasienhipertensitersebut yang didiagnosisdanmendapatkanperawatan. Diabetes melitus (DM) adalahpenyakitgangguanmetabolisme yang ditandaidengankadarglukosadarahmelebihinilai normal atauhiperglikemia (≥200 mg/dl). Data daririsetkesehatandasar2013, prevalensi DM sebayak2,1% danhanya50% yang sadar (diantaranya 30% yang mauberobatteratur).
Analisisefektivitasbiayadigunakan agar dapatmembantudalammengambilkeputusanpemilihanobat yang
efektifsecaramanfaatdanbiaya.
Tujuanpenelitianiniadalahuntukmengevaluasiefektivitasbiayaantihipertensi dananti diabetic padapasien yang dirawatinap di RumahSakitUmumPusat (RSUP) Haji Adam Malik Medan.
Penelitianinibersifatnon-eksperimentaldenganmenggunakan data yang diambildarirekammedispasiensecararetrospektifperiodeJanuari 2014 - Juni 2014. Metodeanalisisbiaya yang digunakanadalahCost Effectiveness Analysis (CEA).MetodeCost Effectiveness Average Ratio (CEA Ratio) danIncremental
Cost Effectiveness Ratio (ICER)
digunakanuntukmenganalisisantihipertensidanantidiabetik yang paling cost-effective.
Hasilpenelitianmenunjukkanregimenterapiantihipertensi yang digunakanialahamlodipin, captopril, valsartan, amlodipin+ captopril, amlodipin+
valsartan, captoril+ valsartan danamlodipin+ captopril+ valsartan.Padaregimenterapiantidiabetik yang digunakanialah analog insulin, metformin dan analog insulin+ metformin.
Antihipertensi yang paling cost-effectiveberdasarkan CEAdan ICER adalahamlodipin+ captopril danantidiabetik yang paling cost-effective berdasarkan CEAdan ICER adalah metformin.
Kata kunci:Hipertensidan Diabetes Melitus, AntihipertensidanAntidiabetik, AnalisisEfektivitasBiaya, RSUP H. Adam Malik Medan.
vii
COST EFFECTIVENESS ANALYSIS OF HYPERTENSION
AND DIABETES MELLITUS TREATMENT
IN HAJI ADAM MALIK PUBLIC HOSPITAL
PERIOD JANUARY 2014 - JUNE 2014
ABSTRACT
Hypertension is a condition where increased blood pressure levels exceeds the normal value(≥140/90 mmHg). Prevalence in Indonesia 32.2% and only 24.4% of patients with hypertension are diagnosed and get treatment.Diabetes mellitus (DM) is a chronic metabolic disorder characterized by blood glucose levels exceeded the normal value or hyperglycemia(≥200 mg/dl) . Data from basic health research 2013, prevalence DM 2.1% and only 50% were aware (including 30% were treated regulary).Health financing in Indonesia has increased, cost-effectiveness analysis is needed to assist in decision these medicines are effective in benefit and costs.
This study aimed was to evaluate cost effectivenessof antihypertensive and antidiabetic provided to inpatients in Haji Adam Malik Public Hospital of Medan.
This research was a non-eksperimental and used retrospective method. This study was undertaken using medical record of patients at period of January 2014 - June 2014. The evaluation was conducted using Cost-Effectiveness
Analysis (CEA) method. Cost Effectiveness Average Ratio (CEA Ratio) and
Incremental Cost Effectiveness Ratio (ICER) methods were used to analyze model of antihypertensive andantidiabetic therapy which is the most cost-effective one.
The result of this study showed thatantihypertensive treatment areamlodipin, captopril, valsartan, amlodipin+ captopril, amlodipin+ valsartan, captoril+ valsartan danamlodipin+ captopril+ valsartan. Antidiabetictreatmentareanalog insulin, metforminand analog insulin+ metformin.
Antihypertensive therapy which is the most cost-effective based CEA and ICER is amlodipin+ captopril andantidiabetictherapy which is the most cost-effective based CEA and ICER is metformin.
Keywords:Hypertension and Diabetes Mellitus, Antihypertensive and Antidiabetic, Cost Effectiveness Analysis,RSUP H. Adam Malik Medan.
